Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WADA, T.
Right arrow Articles by YOKOYAMA, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WADA, T.
Right arrow Articles by YOKOYAMA, H.
J Am Soc Nephrol 11:1534-1541, 2000
© 2000 American Society of Nephrology

BRIEF COMMUNICATION

A New Anti-Inflammatory Compound, FR167653, Ameliorates Crescentic Glomerulonephritis in Wistar-Kyoto Rats

TAKASHI WADA*, KENGO FURUICHI*, NORIHIKO SAKAI*, YASUNORI IWATA*, KEIICHI YOSHIMOTO*, MIHO SHIMIZU*, KEN-ICHI KOBAYASHI*, NAOFUMI MUKAIDA{dagger}, KOUJI MATSUSHIMA{ddagger} and HITOSHI YOKOYAMA*

* First Department of Internal Medicine and Division of Blood Purification, School of Medicine, Kanazawa University, Kanazawa, Japan
{dagger} Department of Molecular Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
{ddagger} Department of Molecular Preventive Medicine, School of Medicine, The University of Tokyo, Tokyo, Japan.

Correspondence to Dr. Takashi Wada, First Department of Internal Medicine, Kanazawa University School of Medicine, 13-1 Takara-machi, Kanazawa 920-8641, Japan. Phone: +81-76-265-2000, extension 3462; Fax: +81-76-234-4250; E-mail: twada{at}medf.m.kanazawa-u.ac.jp

Abstract

Abstract. The pathophysiologic effects of FR167653 were investigated in a model of crescentic glomerulonephritis induced by a small dose of nephrotoxic serum in Wistar-Kyoto rats. The rats developed crescentic glomerulonephritis by 6 d after the administration of serum. The subcutaneous administration of FR167653 (32 mg/kg) markedly decreased the severity of the renal damage. In a group of rats treated with FR167653 daily from day 0 to day 6, glomerular damage, including crescent formation and proteinuria, was virtually absent. FR167653 markedly decreased urinary levels of monocyte chemoattractant protein-1 (MCP-1). In addition, FR167653 reduced production of MCP-1 protein and transcripts in the diseased kidneys. In a group of rats for which treatment was initiated on day 3, shortly after the appearance of glomerular abnormalities, the progression of renal disease was appreciably retarded, with partial inhibition of MCP-1. In contrast, when rats were treated only on the first day, no beneficial effects were observed and severe proliferative and necrotizing glomerulonephritis, with crescent formation, was induced by day 6, with the upregulation of MCP-1. These results suggest that FR167653 may be effective against crescentic glomerulonephritis, possibly via the inhibition of MCP-1. In addition, there was marked reduction in renal injury even when FR167653 treatment was initiated after glomerular inflammation was established, suggesting that the therapeutic application of FR167653 may be clinically useful for human renal diseases.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
M. Nishida, Y. Okumura, H. Sato, and K. Hamaoka
Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy
Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2520 - 2524.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
D.-S. Jung, J. J. Li, S.-J. Kwak, S. H. Lee, J. Park, Y. S. Song, T.-H. Yoo, S. H. Han, J. E. Lee, D. K. Kim, et al.
FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells
Am J Physiol Renal Physiol, August 1, 2008; 295(2): F595 - F604.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. Sheryanna, G. Bhangal, J. McDaid, J. Smith, A. Manning, B. M.J. Foxwell, M. Feldmann, H. T. Cook, C. D. Pusey, and F. W.K. Tam
Inhibition of p38 Mitogen-Activated Protein Kinase Is Effective in the Treatment of Experimental Crescentic Glomerulonephritis and Suppresses Monocyte Chemoattractant Protein-1 but Not IL-1beta or IL-6
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1167 - 1179.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. Yamahana, T. Wada, K. Furuichi, N. Sakai, H. Yokoyama, and S. Kaneko
TAK-603, an anti-inflammatory compound, reduces crescentic glomerulonephritis and preserves renal function in WKY rats
Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2736 - 2744.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
A. R. Olzinski, T. A. McCafferty, S. Q. Zhao, D. J. Behm, M. E. Eybye, K. Maniscalco, R. Bentley, K. S. Frazier, C. M. Milliner, R. C. Mirabile, et al.
Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection
Cardiovasc Res, April 1, 2005; 66(1): 170 - 178.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Wang, J. H. Kwak, S. I. Kim, Y. He, and M. E. Choi
Transforming Growth Factor-{beta}1 Stimulates Vascular Endothelial Growth Factor 164 via Mitogen-activated Protein Kinase Kinase 3-p38{alpha} and p38{delta} Mitogen-activated Protein Kinase-dependent Pathway in Murine Mesangial Cells
J. Biol. Chem., August 6, 2004; 279(32): 33213 - 33219.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. Stambe, D. J. Nikolic-Paterson, P. A. Hill, J. Dowling, and R. C. Atkins
p38 Mitogen-Activated Protein Kinase Activation and Cell Localization in Human Glomerulonephritis: Correlation with Renal Injury
J. Am. Soc. Nephrol., February 1, 2004; 15(2): 326 - 336.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
L. Aoudjit, M. Stanciu, H. Li, S. Lemay, and T. Takano
p38 Mitogen-activated protein kinase protects glomerular epithelial cells from complement-mediated cell injury
Am J Physiol Renal Physiol, October 1, 2003; 285(4): F765 - F774.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
Y. Iwata, T. Wada, K. Furuichi, N. Sakai, K. Matsushima, H. Yokoyama, and K.-i. Kobayashi
p38 Mitogen-Activated Protein Kinase Contributes to Autoimmune Renal Injury in MRL-Faslpr Mice
J. Am. Soc. Nephrol., January 1, 2003; 14(1): 57 - 67.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Matsuoka, T. Arai, M. Mori, S. Goya, H. Kida, H. Morishita, H. Fujiwara, I. Tachibana, T. Osaki, and S. Hayashi
A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L103 - L112.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
N. Sakai, T. Wada, K. Furuichi, Y. Iwata, K. Yoshimoto, K. Kitagawa, S. Kokubo, M. Kobayashi, S.-i. Takeda, H. Kida, et al.
p38 MAPK phosphorylation and NF-{kappa}B activation in human crescentic glomerulonephritis
Nephrol. Dial. Transplant., June 1, 2002; 17(6): 998 - 1004.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673